Thrombotic RIsk FActors in AL-goneurodystrophy

Enrolling by invitation

Conditions studied: Algoneurodystrophy

In brief

The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Key facts

Study ID

NCT07435207

Run by

Fondazione IRCCS Policlinico San Matteo di Pavia

People needed

120

Starts

2026-01-26

Expected to finish

2027-06-30

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Fondazione IRCCS Policlinico San Matteo di Pavia — Pavia, Pavia, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.